A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

  1. Tabernero, J.
  2. Climent, M.A.
  3. Lluch, A.
  4. Albanell, J.
  5. Vermorken, J.B.
  6. Barnadas, A.
  7. Antón, A.
  8. Laurent, C.
  9. Mayordomo, J.I.
  10. Estaun, N.
  11. Losa, I.
  12. Guillem, V.
  13. Garcia-Conde, J.
  14. Tisaire, J.L.
  15. Baselga, J.
Journal:
Annals of Oncology

ISSN: 0923-7534

Year of publication: 2004

Volume: 15

Issue: 9

Pages: 1358-1365

Type: Article

DOI: 10.1093/ANNONC/MDH349 GOOGLE SCHOLAR lock_openOpen access editor